StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Lonza Group AG
Swiss Stock Exchange:LONN.SW
Sector
Location
Market Cap
USD 49.71 B
Share Price
USD 707.88
Avg Daily Volume
150,788
Change (1 day)
-0.71%
Change (1 year)
22.09%
Change (YTD)
19.48%
Lonza Group AG Accounts Payable for the year ending December 31, 2024: USD 447.04 M
Lonza Group AG Accounts Payable is USD 447.04 M for the year ending December 31, 2024, a -19.58% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Lonza Group AG Accounts Payable for the year ending December 31, 2023 was USD 555.86 M, a 7.76% change year over year.
-
Lonza Group AG Accounts Payable for the year ending December 31, 2022 was USD 515.83 M, a -2.57% change year over year.
-
Lonza Group AG Accounts Payable for the year ending December 31, 2021 was USD 529.42 M, a 52.17% change year over year.
-
Lonza Group AG Accounts Payable for the year ending December 31, 2020 was USD 347.92 M, a -25.60% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Hansoh Pharmaceutical Group Company Limited
USD 4.01
3692.HK
-0.05
-1.25%
Summit Therapeutics Inc.
USD 25.00
SMMT
-0.88
-3.40%
Insmed Incorporated
USD 98.18
INSM
+1.52
1.57%
Torrent Pharmaceuticals Limited
USD 38.57
TORNTPHARM.NS
-0.37
-0.96%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
Regeneron Pharmaceuticals, Inc.
USD 567.74
REGN
+7.98
1.43%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.93
600276.SS
-0.09
-1.14%
Takeda Pharmaceutical Company Limited
USD 29.69
4502.T
+0.05
0.17%
Ucb S.A.
USD 199.81
UCB.BR
-2.13
-1.05%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Hansoh Pharmaceutical Group Company Limited
USD 4.01
3692.HK
-0.05
-1.25%
Summit Therapeutics Inc.
USD 25.00
SMMT
-0.88
-3.40%
Insmed Incorporated
USD 98.18
INSM
+1.52
1.57%
Torrent Pharmaceuticals Limited
USD 38.57
TORNTPHARM.NS
-0.37
-0.96%